Cleared Traditional

K942623 - TRIMPORT

K942623 is an FDA 510(k) clearance for TRIMPORT, manufactured by Gerard Medical Enterprises, Inc.. The device is a Class 2 General Hospital device with product code LJT cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K942623 · Gerard Medical Enterprises, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1994
Decision
88d
Days
Class 2
Risk

K942623 is an FDA 510(k) clearance for the TRIMPORT. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Gerard Medical Enterprises, Inc. (Charlton, US). The FDA issued a Cleared decision on August 23, 1994 after a review of 88 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Gerard Medical Enterprises, Inc. devices

FDA 510(k) Submission Details - K942623

510(k) Number K942623 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 27, 1994
Decision Date August 23, 1994
Days to Decision 88 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 129d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 236
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K942623.
CATHLINK 20 TITANIUM PORT W/ATT. POLYURETHANE CATH
K926139 · Bard Access Systems, Inc. · Jan 1995
VITAL-PORT VASC ACCESS SYS W/DUAL LUM INJECTROL CA
K932411 · Med Institute, Inc. · Sep 1994
VITAL-PORT VASCULAR ACCESS SYSTEM
K934520 · Med Institute, Inc. · Sep 1994
THEREX LOW-PROFILE PORT - TITANIUM MODEL
K942412 · Therex Corp. · Aug 1994
PORT-A-CATH LOW PROFILE IMPLANTABLE VENOUS ACCESS SYSTEM
K942024 · Pharmacia Deltec, Inc. · Jul 1994
L-CATH CATHETER SYSTEM - PORT L-CATH
K942103 · Luther Medical Products, Inc. · Jul 1994